Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

How to Use Melatonin in Clinical Practice

IntraBalance

N. Bhopal

"I'm Dizzy" - Evaluation of the Dizzy Patient

Medical College of Georgia - Augusta University

J. Switzer

Cognitive Disorders

ZINCARE

M. Mataa

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Embracing Aging: Helping Our Loved Ones, Helping Ourselves

Pacific Neuroscience Institute

S. Kaiser, A. Effinger

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Aducanumab: What Neurologists Should Know - Clinical Impact, Indicat…

Northwestern Medicine Neurology and Neurosurgery

I. Grant

Treatment Tips for Essential Tremor

Aparna Wagle Shukla

Updates in Dementia

2023 Conference Coverage

P. Tipton

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Neuropsychological Assessment in Dementia Diagnosis

Northwestern Medicine Neurology and Neurosurgery

S. Weintraub

Central Disorders of Hypersomnolence

University Hospitals

J. C. Andrefsky

Preventing Cognitive Decline with Lithium

Psychiatry Redefined

J. Greenblatt

Lewy Body Dementia: The Most Common Disease You Never Heard Of - 2024

AdventHealth

J. Galvin

Alzheimer's: Clinical Pearls

Lawrence Robbins

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay